Walgreens nasal spray recall: Over 41,000 bottles pulled after testing finds Pseudomonas lactis contamination
Deerfield, Illinois (Times Media Service) — Walgreens has issued a nationwide recall of more than 41,000 bottles of Walgreens Saline Nasal Spray with Xylitol after laboratory tests found contamination with the bacterium Pseudomonas lactis in specific lots; consumers should stop use and return product.
- Product recalled: Walgreens Saline Nasal Spray with Xylitol, 1.5 oz (45 mL), NDC 0363-3114-01.
- Scope: More than 41,000 bottles nationwide; affected lots 71409 (exp. 02/28/2027) and 71861 (exp. 08/31/2027).
- Contaminant & risk: Pseudomonas lactis; FDA Class II recall — could cause temporary or medically reversible health problems, especially in vulnerable people.
- Consumer action: Stop using matching bottles and return them to any Walgreens for a refund; contact your health provider if you are high-risk.
What was recalled and why
Federal and local notices indicate a supplier, operating under FDA guidance, initiated a voluntary recall after laboratory testing found Pseudomonas lactis in specific lots of Walgreens Saline Nasal Spray with Xylitol (1.5-oz bottles, NDC 0363-3114-01). The recall covers lot 71409 (exp. 02/28/2027) and lot 71861 (exp. 08/31/2027) sold at Walgreens stores nationwide.
Sources: Scripps News, Taunton civic alert, 10News.
About Pseudomonas lactis and health risk
Pseudomonas is a broad family of bacteria; while Pseudomonas lactis is less well-known than some species, officials note bacteria in this group can cause infections when introduced to body tissues or mucous membranes. Health authorities emphasize that people with compromised immune systems, chronic lung disease, or other respiratory conditions face greater risk from exposure in the nasal passages.
At the time of reporting, officials stated no confirmed illnesses have been linked to the recalled bottles. The Independent and the Taunton notice summarize the risk profile and current status.
Regulatory angle and supplier action
Public notices report a voluntary recall by the supplier after contamination was detected during testing performed under FDA direction. A voluntary recall typically means the manufacturer identified a problem and moved to limit harm rather than awaiting forced action. Still, this raises questions about manufacturing controls, environmental monitoring, and testing frequency at the supplier’s site.
For technical details and the official recall classification, see Scripps News and the Taunton civic alert.
What consumers should do now
- Stop using any Walgreens Saline Nasal Spray with Xylitol that matches lot 71409 (exp. 02/28/2027) or lot 71861 (exp. 08/31/2027), NDC 0363-3114-01.
- Return the bottle to any Walgreens store for a refund. For details, see the Taunton recall notice.
- If you are immunocompromised, pregnant, elderly, or have chronic lung disease, contact your doctor or local health department if you used the product.
- For recall questions, contact Walgreens customer service or consult media reports such as Scripps News and 10News.
Investigative questions for retailers and regulators
This recall prompts several lines of inquiry for regulators, the supplier, and Walgreens:
- How did contaminated product pass final release testing or move through distribution before detection?
- What environmental controls existed at the supplier’s manufacturing site to prevent bacterial contamination?
- Were routine sterility or microbial limit tests performed on finished lots, and how frequently?
- How many bottles from the two affected lots reached consumers in each state and region?
- What corrective actions will the supplier take, and how will the FDA verify those fixes?
Media reports and municipal notices show the supplier initiated the voluntary recall after finding contamination. Local public records are needed to fully map distribution and remedial steps.
Background: timing and market context
The recall occurs during cold and flu season when demand for over-the-counter nasal treatments is higher. Saltwater nasal sprays are widely used for allergies and congestion, increasing the chance that recently purchased bottles could be affected. Health officials advise checking packaging for NDC and lot numbers before use.
No illnesses reported so far
Available sources report no confirmed cases of illness tied to the recalled bottles. Nonetheless, the FDA’s Class II designation emphasizes preventing temporary or medically reversible adverse health consequences, particularly among high-risk groups. See reporting from Scripps News and The Independent.
Implications for Walla Walla, Washington
Local Walgreens stores in Walla Walla may need to remove affected lots from shelves and return product to distribution, creating modest operational work for staff. Consumers will be eligible for refunds, but those relying on this product will need alternatives.
Public health stakeholders — hospitals, long-term-care facilities, pharmacies, and clinics — should check inventories for the affected NDC and lot numbers and notify vulnerable patients to discard any matching bottles and seek care if symptoms develop after use.
Accountability and follow-up in the community
Residents and local officials should request transparent updates about how many bottles were distributed in the region and what steps Walgreens and the supplier will take to prevent recurrence. Public confidence depends on clear, timely information and visible corrective actions from manufacturers and retailers.
Sources and further reading
- Scripps News: Nasal spray recalled over contamination concerns
- 10News: Nasal spray recalled over contamination concerns
- Taunton, Massachusetts civic alert (recall notice with lot and NDC details)
- The Independent: Walgreens nasal spray recall story
For recall questions, consumer guidance, or to return affected product: contact Walgreens customer service or visit your local Walgreens. For official lot and NDC details, consult the Taunton civic alert and reporting from Scripps News.
